---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-021442"
form_type: "8-K"
ticker: "URGN"
cik: "0001668243"
company_name: "UroGen Pharma Ltd."
filed_at: "2026-06-23T20:14:22+00:00"
generated_at: "2026-06-23T20:15:13.447505+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# UroGen shareholders approve 1M share equity plan increase, re-elect all directors

## Summary
- Shareholders approved 2017 Equity Incentive Plan amendment adding 1,000,000 ordinary shares to the reserve.
- All seven director nominees elected: Arie Belldegrun, Elizabeth Barrett, Cynthia Butitta, Stuart Holden, James Robinson, Leana Wen, Daniel Wildman.
- Advisory vote on executive compensation approved (25.1M for, 3.2M against).
- PricewaterhouseCoopers LLP ratified as independent auditor for upcoming year (36.8M for).
- Articles of Association amended to align shareholder proposal eligibility with Israeli Companies Law.

## SEC filing metadata
- accession: 0001437749-26-021442
- form_type: 8-K
- ticker: URGN
- cik: 0001668243
- company_name: UroGen Pharma Ltd.
- filed_at: 2026-06-23T20:14:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668243/000143774926021442/0001437749-26-021442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668243/000143774926021442/urgn20260622_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-021442
- JSON: https://secwatch.observer/filing/0001437749-26-021442.json
- Plain text: https://secwatch.observer/filing/0001437749-26-021442.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.